From this 10Q:
Elite’s revenue derived from phentermine 37.5mg tablets during the six months ended September 30, 2011 was approximately $308k, with such amount including a $145k milestone payment triggered by the first shipment of the product, $123k in manufacturing revenues and $33k in royalties paid pursuant to the Precision Dose Agreement . This is for the 6 mos and you have 144k for the year, where are you getting your numbers.